|
1
|
Sunil PM, Ramachandran CR, Arulmoli, Devi
S and Soma SV: Cytogenetic alterations in oral squamous cell
carcinoma detected by karyotyping (g-banding). OMPJ. 2:89–95.
2011.
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Scully C: Oral cancer aetiopathogenesis;
past, present and future aspects. Med Oral Patol Oral Cir Bucal.
16:e306–e311. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Llewellyn CD, Johnson NW and
Warnakulasuriya KA: Risk factors for squamous cell carcinoma of the
oral cavity in young people - a comprehensive literature review.
Oral Oncol. 37:401–418. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sugerman PB and Savage NW: Current
concepts in oral cancer. Aust Dent J. 44:147–156. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gupta S, Kong W, Peng Y, Miao Q and
Mackillop WJ: Temporal trends in the incidence and survival of
cancers of the upper aerodigestive tract in Ontario and the United
States. Int J Cancer. 125:2159–2165. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tang J, Feng Y, Tsao S, Wang N, Curtain R
and Wang Y: Berberine and Coptidis rhizoma as novel antineoplastic
agents: a review of traditional use and biomedical investigations.
J Ethnopharmacol. 126:5–17. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen TC, Lai KC, Yang JS, et al:
Involvement of reactive oxygen species and caspase-dependent
pathway in berberine-induced cell cycle arrest and apoptosis in C6
rat glioma cells. Int J Oncol. 34:1681–1690. 2009.PubMed/NCBI
|
|
9
|
Liu B, Wang G, Yang J, Pan X, Yang Z and
Zang L: Berberine inhibits human hepatoma cell invasion without
cytotoxicity in healthy hepatocytes. PLoS One. 6:e214162011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hwang JM, Kuo HC, Tseng TH, Liu JY and Chu
CY: Berberine induces apoptosis through a mitochondria/caspases
pathway in human hepatoma cells. Arch Toxicol. 80:62–73. 2006.
View Article : Google Scholar
|
|
11
|
Kim JS, Ellman MB, An HS, van Wijnen AJ,
Borgia JA and Im HJ: Insulin-like growth factor 1 synergizes with
bone morphogenetic protein 7-mediated anabolism in bovine
intervertebral disc cells. Arthritis Rheum. 62:3706–3715. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Brinkman BM and Wong DT: Disease mechanism
and biomarkers of oral squamous cell carcinoma. Curr Opin Oncol.
18:228–233. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sundin T, Peffley DM and Hentosh P:
Disruption of an hTERT-mTOR-RAPTOR protein complex by a
phytochemical perillyl alcohol and rapamycin. Mol Cell Biochem.
375:97–104. 2013.PubMed/NCBI
|
|
14
|
Jiang Q, Liu P, Wu X, et al: Berberine
attenuates lipopolysaccha-ride-induced extracelluar matrix
accumulation and inflammation in rat mesangial cells: involvement
of NF-κB signaling pathway. Mol Cell Endocrinol. 331:34–40. 2011.
View Article : Google Scholar
|
|
15
|
Lin K, Liu S, Shen Y and Li Q: Berberine
attenuates cigarette smoke-induced acute lung inflammation.
Inflammation. 36:1079–1086. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bandyopadhyay S, Patra PH, Mahanti A, et
al: Potential antibacterial activity of berberine against multi
drug resistant enterovirulent Escherichia coli isolated from yaks
(Poephagus grunniens) with haemorrhagic diarrhoea. Asian Pac J Trop
Med. 6:315–319. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tan Y, Tang Q, Hu BR and Xiang JZ:
Antioxidant properties of berberine on cultured rabbit corpus
cavernosum smooth muscle cells injured by hydrogen peroxide. Acta
Pharmacol Sin. 28:1914–1918. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou JY and Zhou SW: Protective effect of
berberine on anti-oxidant enzymes and positive transcription
elongation factor b expression in diabetic rat liver. Fitoterapia.
82:184–189. 2011. View Article : Google Scholar
|
|
19
|
Tan YL, Goh D and Ong ES: Investigation of
differentially expressed proteins due to the inhibitory effects of
berberine in human liver cancer cell line HepG2. Mol Biosyst.
2:250–258. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Iizuka N, Miyamoto K, Okita K, et al:
Inhibitory effect of Coptidis Rhizoma and berberine on the
proliferation of human esophageal cancer cell lines. Cancer Lett.
148:19–25. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fukuda K, Hibiya Y, Mutoh M, Koshiji M,
Akao S and Fujiwara H: Inhibition by berberine of cyclooxygenase-2
transcriptional activity in human colon cancer cells. J
Ethnopharmacol. 66:227–233. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Marverti G, Ligabue A, Lombardi P, et al:
Modulation of the expression of folate cycle enzymes and polyamine
metabolism by berberine in cisplatin-sensitive and -resistant human
ovarian cancer cells. Int J Oncol. 43:1269–1280. 2013.PubMed/NCBI
|
|
23
|
Yan K, Zhang C, Feng J, et al: Induction
of G1 cell cycle arrest and apoptosis by berberine in bladder
cancer cells. Eur J Pharmacol. 661:1–7. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma X, Zhou J, Zhang CX, et al: Modulation
of drug-resistant membrane and apoptosis proteins of breast cancer
stem cells by targeting berberine liposomes. Biomaterials.
34:4452–4465. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fu L, Chen W, Guo W, et al: Berberine
targets AP-2/hTERT, NF-κB/COX-2, HIF-1α/VEGF and
cytochrome-c/caspase signaling to suppress human cancer cell
growth. PLoS One. 8:e692402013. View Article : Google Scholar
|
|
26
|
Yip NK and Ho WS: Berberine induces
apoptosis via the mitochondrial pathway in liver cancer cells.
Oncol Rep. 30:1107–1112. 2013.PubMed/NCBI
|
|
27
|
Wang N, Feng Y, Zhu M, et al: Berberine
induces autophagic cell death and mitochondrial apoptosis in liver
cancer cells: the cellular mechanism. J Cell Biochem.
111:1426–1436. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Patil JB, Kim J and Jayaprakasha GK:
Berberine induces apoptosis in breast cancer cells (MCF-7) through
mitochondrial-dependent pathway. Eur J Pharmacol. 645:70–78. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ho YT, Lu CC, Yang JS, et al: Berberine
induced apoptosis via promoting the expression of caspase-8, -9 and
-3, apoptosis-inducing factor and endonuclease G in SCC-4 human
tongue squamous carcinoma cancer cells. Anticancer Res.
29:4063–4070. 2009.PubMed/NCBI
|
|
30
|
Lin CC, Yang JS, Chen JT, et al: Berberine
induces apoptosis in human HSC-3 oral cancer cells via simultaneous
activation of the death receptor-mediated and mitochondrial
pathway. Anticancer Res. 27:3371–3378. 2007.PubMed/NCBI
|
|
31
|
Zheng F, Tang Q, Wu J, et al: p38α
MAPK-mediated induction and interaction of FOXO3a and p53
contribute to the inhibited-growth and induced-apoptosis of human
lung adenocarcinoma cells by berberine. J Exp Clin Cancer Res.
33:362014. View Article : Google Scholar
|
|
32
|
Yan L, Yan K, Kun W, et al: Berberine
inhibits the migration and invasion of T24 bladder cancer cells via
reducing the expression of heparanase. Tumour Biol. 34:215–221.
2013. View Article : Google Scholar
|
|
33
|
Park JJ, Seo SM, Kim EJ, et al: Berberine
inhibits human colon cancer cell migration via AMP-activated
protein kinase-mediated downregulation of integrin β1 signaling.
Biochem Biophys Res Commun. 426:461–467. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Singh T, Vaid M, Katiyar N, Sharma S and
Katiyar SK: Berberine, an isoquinoline alkaloid, inhibits melanoma
cancer cell migration by reducing the expressions of
cyclooxygenase-2, prostaglandin E2 and prostaglandin
E2 receptors. Carcinogenesis. 32:86–92. 2011. View Article : Google Scholar
|
|
35
|
Ho YT, Yang JS, Li TC, et al: Berberine
suppresses in vitro migration and invasion of human SCC-4 tongue
squamous cancer cells through the inhibitions of FAK, IKK, NF-κB,
u-PA and MMP-2 and -9. Cancer Lett. 279:155–162. 2009. View Article : Google Scholar : PubMed/NCBI
|
